UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000027060
Receipt No. R000031001
Scientific Title A Study on Ability to Detect Early Deterioration of Heart Failure with Respiratory Instability Telemonitoring - Aided by Innovative Tele-Monitoring Environment To Halt Ongoing Deterioration of Heart Failure: ITMETHOD-HF -
Date of disclosure of the study information 2017/05/08
Last modified on 2019/05/02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A Study on Ability to Detect Early Deterioration of Heart Failure with Respiratory Instability Telemonitoring
- Aided by Innovative Tele-Monitoring Environment To Halt Ongoing Deterioration of Heart Failure: ITMETHOD-HF -
Acronym ITMETHOD-HF
Scientific Title A Study on Ability to Detect Early Deterioration of Heart Failure with Respiratory Instability Telemonitoring
- Aided by Innovative Tele-Monitoring Environment To Halt Ongoing Deterioration of Heart Failure: ITMETHOD-HF -
Scientific Title:Acronym ITMETHOD-HF
Region
Japan

Condition
Condition Chronic Heart Failure
Classification by specialty
Cardiology Vascular surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate that calculated Respiratory Stability Index (RSI) with remote monitoring in patients with chronic heart failure detects earlier deterioration of heart failure.
Basic objectives2 Others
Basic objectives -Others Usefullness of RSI as an early detection index
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Sensitivity of RSI
RSI levels of subjects clinically diagnosed as worsening heart failure by the investigator is decreased (1 day or more that the RSI is less than 20) prior to exacerbation.

Specificity of RSI
RSI levels of subjects clinically diagnosed stable heart failure by the investigator is not decreased less than 20 on the judgment day.
Key secondary outcomes -Days of RSI decrease (less than 20) preceding exacerbation of heart failure
-RSI cutoff value
-Malfunctions of home telemonitoring
-Inter-day variations in RSI

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Device,equipment
Interventions/Control_1 To collect parameters using ITMETHOD remote monitoring system with noninvasive pressure sensor sheet and calculate RSI under home environment [ Time Frame: Intervention period (48 weeks) ]
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. Patients with chronic heart failure under treatment (Including patients after heart transplantation or myoblast cell-sheet transplantation)
2. New York Heart Association (NYHA) class II, III and IV
3. Patients must have been hospitalized within 12 months or treated with increases in dose and/or changes in medications for exacerbation of heart failure.
4. Regular visits to our trial sites or affiliated hospitals
5. Daily internet access available in patients' bedrooms
6. Patients with 20 years of age or older at the time of their written consent
7. Patients who provided written informed consent
Key exclusion criteria 1. Patients who share a bed with other person or pets
2. Patients who are not considered able to measure overnight respiratory due to physical factors or lifestyle factors
3. Patients without spontaneous respiration
4. Patients with chronic respiratory failure or chronic obstructive pulmonary disease
5. Patients must not have started to use CPAP or ASV during sleep within a month
6. Patients whose QOL is limited by malignant tumor or other diseases
7. Patients who have sequela as the result of cerebrovascular disorder
8. Patients diagnosed with dementia
9. Patients who are inability to provide informed consent or doubted for his/her agreement
10. Any other patients who are determined as unsuitable for this study by the investigators
Target sample size 40

Research contact person
Name of lead principal investigator
1st name Shigeru
Middle name
Last name Miyagawa
Organization Osaka University Graduate School of Medicine
Division name Cardiovascular surgery
Zip code 565-0871
Address 2-2 Yamadaoka, Suita, Osaka
TEL 06-6879-3154
Email miyagawa@surg1.med.osaka-u.ac.jp

Public contact
Name of contact person
1st name Mika
Middle name
Last name Sakoda
Organization Osaka University Graduate School of Medicine
Division name Cardiovascular surgery
Zip code 565-0871
Address 2-2 Yamadaoka, Suita, Osaka
TEL 06-6879-3154
Homepage URL
Email m-sakoda@surg1.med.osaka-u.ac.jp

Sponsor
Institute Osaka University Graduate School of Medicine, Cardiovascular surgery
Institute
Department

Funding Source
Organization Japan Agency for Medical Research and Development
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka University Clinical Research Review Committee
Address 2-2 Yamadaoka, Suita, Osaka 565-0871 Japan
Tel 06-6210-8296
Email rinri@hp-crc.med.osaka-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪大学医学部附属病院(大阪府)、射水市民病院(富山県)、JCHO高岡ふしき病院(富山県)、田附興風会医学研究所 北野病院(大阪府)、のぞみハートクリニック(東京都)、三重大学医学部附属病院(三重県)、ゆみのハートクリニック(大阪府)

Other administrative information
Date of disclosure of the study information
2017 Year 05 Month 08 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 18
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 02 Month 01 Day
Date of IRB
2017 Year 04 Month 26 Day
Anticipated trial start date
2017 Year 04 Month 26 Day
Last follow-up date
2019 Year 03 Month 20 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2017 Year 04 Month 19 Day
Last modified on
2019 Year 05 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031001

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.